Selank 0.15% is an anxiolytic peptide drug with nootropic properties usually sold as a nasal spray or drops. By its structure, Selank is based on endogenous tetrapeptide Tuftsin, which plays an important role in the immune system. To slow the breakdown of peptides and prolong its effects, the inventors of Selank added a Glyproline to its structure.
Tuftsin was found to have anxiolytic effects in 1995 and over the next decade, Russian scientists were focusing on developing a peptide drug that was able to have the most pronounced anxiolytic effects. This research, as well as clinical trials, lasted until 2009 when Selank was finally brought to market under the brand name Selank 0.15%. It is produced in a GMP-compliant factory by Peptogen Inc.
Dosage and administration
One bottle of Selank contains 60 drops, each having 75 mcg of the active ingredient. The average dose is 2-3 drops in each nostril. Selank should be taken up to 3 times per day.
On-label regimen of Selank is 3 times a day, 2 drops in each nostril, for a period of 14 days.
Side effects
Irritation of the nasal mucosa and very rare allergic reactions.
Overdose
Selank was shown to be completely safe even when hundredfold doses were administered.
Drug interaction
Selank has no effect on depressants or stimulants including Haloperidol, Pentobarbital, Hexobarbital, and analeptics. It can be combined with psychotherapy. It is safe to use with ethanol-containing substances.
Note
If there is a need to increase the effect of Selank, a second dose should be taken 15-minutes after the first one.
Storage conditions
Keep in a dark place at a temperature less than 10°C (50°F) for up to 2 years.
Manufacturer
Peptogen, Russia.